08:31 EDT Eli Lilly (LLY) to acquire Adverum Biotechnologies (ADVM) for up to $12.47 per share
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly, Incyte report results from BRAVE-AA-PEDS trial
- Eli Lilly reports findings from ADjoin extension trial of Ebglyss
- Eli Lilly’s New Phase 3 Study: A Potential Game-Changer for Alcohol Use Disorder
- Eli Lilly’s New Study on Brenipatide: A Potential Game-Changer for Alcohol Use Disorder
- Trump Trade: Trump administration prepares new probe into pharma prices